Latanmono Conserveermiddelvrij (Latanoprost)

Latanoprost is a prostaglandin F (FP) receptor agonist. By binding to these receptors in the eye, it increases the uveoscleral outflow of aqueous humor, which reduces intra‑ocular pressure and mitigates the risk of glaucoma‑related optic nerve damage.

The dosing regimen is determined by the prescribing clinician. Typically, one drop is instilled in the affected eye(s) once daily in the evening, but the exact dose and frequency should follow the prescriber’s instructions.

Safety data for latanoprost in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies the potential risk, and the decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong intra‑ocular pressure reduction. Compared with beta‑blocker eye drops, it often provides greater pressure‑lowering efficacy and a different side‑effect profile, such as increased eyelash growth and iris darkening.

Store the ophthalmic solution at room temperature, preferably below 25 °C. Keep the bottle in its original packaging, protect it from light and moisture, and ensure the cap is tightly closed to maintain sterility.

The medication is applied as a single drop into the affected eye(s) once daily, usually in the evening. Patients should wash their hands before use, avoid touching the tip of the bottle to the eye or any surface, and wait a few minutes before applying other eye drops.

Serious risks, though rare, include severe allergic reactions, uveitis, macular edema, and sudden loss of vision. Patients should seek immediate medical attention if they experience eye pain, redness, swelling, visual changes, or any signs of infection.

The product should be avoided in individuals with known hypersensitivity to latanoprost or any component of the formulation, as well as in eyes with active inflammation, infection, or recent ocular surgery unless directed by a specialist.